Detalhe da pesquisa
1.
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
N Engl J Med
; 378(4): 321-330, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365294
2.
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 46(5): 1152-1163, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610252
3.
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline.
Eur J Nucl Med Mol Imaging
; 44(3): 382-391, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27633250
4.
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
Alzheimers Dement
; 13(3): 274-284, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341065
5.
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
Alzheimers Dement
; 13(3): 285-295, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341066
6.
Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aß42 and influence of disease on the total-Aß42/Aß40 ratio.
J Neurochem
; 135(5): 1049-58, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26332787
7.
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
Alzheimers Dement
; 11(10): 1180-90, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533203
8.
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Alzheimers Dement
; 11(11): 1316-28, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25676388
9.
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?
Alzheimers Dement
; 10(6): 713-723.e2, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24721526
10.
The glial marker YKL-40 is decreased in synucleinopathies.
Mov Disord
; 28(13): 1882-5, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847144
11.
Measurement of Aß1-42 in cerebrospinal fluid is influenced by matrix effects.
J Neurochem
; 120(2): 325-33, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22023354
12.
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease.
J Neural Transm (Vienna)
; 119(7): 833-42, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22622366
13.
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.
Dement Geriatr Cogn Disord
; 33(1): 18-28, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22377499
14.
Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population.
Scand J Prim Health Care
; 29(3): 181-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21740344
15.
The cost of diagnosing dementia in a community setting.
Int J Geriatr Psychiatry
; 25(5): 476-82, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19685441
16.
Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
J Alzheimers Dis
; 16(2): 389-97, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19221428
17.
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.
Ann Neurol
; 63(5): 621-31, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18300284
18.
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Neurosci Lett
; 450(3): 332-5, 2009 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19022350
19.
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
JAMA
; 302(4): 385-93, 2009 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19622817
20.
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein.
Sci Rep
; 9(1): 2460, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792413